Cargando…
(18) F-Fluorodeoxy Glucose and (11) C-Methionine Accumulation in Demyelinating Lesions
Background Few studies have evaluated the accumulation of (18) F-fluorodeoxyglucose (FDG), (11) C-methionine (MET), and other positron emission tomography (PET) tracers in patients with demyelinating disease. Purpose This study aimed to investigate the accumulation of FDG-PET/computed tomography (...
Autores principales: | Tomura, Noriaki, Saginoya, Toshiyuki, Kaneko, Chikako |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665983/ https://www.ncbi.nlm.nih.gov/pubmed/36398309 http://dx.doi.org/10.1055/s-0042-1750012 |
Ejemplares similares
-
Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with (11)C-Methionine PET: Visual Assessment versus Quantitative Assessment
por: Minamimoto, Ryogo, et al.
Publicado: (2015) -
F-18 Fluorodeoxy Glucose Positron Emission Tomography/Computed Tomography Findings in a Rare Case of Penile Leiomyosarcoma
por: Manohar, Kuruva, et al.
Publicado: (2011) -
(18)F‐fluorodeoxy‐glucose positron emission tomography pattern and prognostic predictors in patients with anti‐GABAB receptor encephalitis
por: Liu, Xiao, et al.
Publicado: (2021) -
Role of (18)F-fluorodeoxyglucose (FDG) and (18)F-2-fluorodeoxy sorbitol (FDS) in autoimmune hypophysitis: a case report
por: Kong, Ziren, et al.
Publicado: (2020) -
Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?
por: Frezza, Anna Maria, et al.
Publicado: (2014)